27 November, 2014
Anders Weilandt joined the Board after an EGM 7th of November 2014. Mr. Weilandt works today as CEO for Diabetes Tools AB since March 2011. Diabetes Tools was rewarded “Medtech Company of the year 2014” by Swedish Medtech and Medtech Magazine. Mr. Weilandt has almost 30 years’ experience of running and managing specialist medtech companies, most with an international focus like Stille AB (2006-2009) and Ascendia AB (2000-2006). He holds an MBA from Copenhagen Business School, Denmark.
If you want to read our press releases, there are available in the Investor Relations section or by clicking the link below.
For questions about Chordate's share price or other investment-related topics, please see if the answer is here.
For questions about the medical effects of the K.O.S treatment, please see if the answer is here.
To get in touch with Chordate regarding other questions, use the adjecent form. We do our best to respond as quickly as possible.